Edward Belongia MD
Director, Center for Clinical Epidemiology & Population Health
Center for Clinical Epidemiology & Population Health
1000 North Oak Ave. ML2 Marshfield, WI 54449
- Internal Medicine, University of Wisconsin Hospital and Clinics-Residency, Madison
- 1978 to 1982:
- MD, Michigan State University, East Lansing
- 1974 to 1978:
- BS, Zoology, University of Michigan, Ann Arbor
- 2009 to Present:
- Adjunct Professor - Department of Population Health Sciences, University of Wisconsin - Madison, Madison
- 1995 to Present:
- Senior Epidemiologist/Director, Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield
- 1990 to 1995:
- Public Health Physician, STD Surveillance and Screening Unit, Minnesota Department of Health, Minneapolis
- 1988 to 1990:
- Epidemic Intelligence Service Officer, Centers for Disease Control and Prevention, U.S. Public Health Service
- 1985 to Present:
- American Board of Internal Medicine
Dr. Belongia is an infectious disease epidemiologist and Director of the Center for Clinical Epidemiology and Population Health at the Marshfield Clinic Research Institute. He leads a research team that has conducted vaccine safety and influenza vaccine effectiveness research for over 12 years in collaboration with CDC. He completed an internal medicine residency at the University of Wisconsin and served as a CDC Epidemic Intelligence Service (EIS) officer. Dr. Belongia is a former member of the CDC Advisory Committee on Immunization Practices (ACIP), and an Adjunct Professor at the University of Wisconsin—Madison. He serves on the ACIP work groups for influenza and herpes zoster vaccines.
Infectious disease epidemiology
Osterholm MT, Kelley NS, Sommer A, Belongia EA. (2012 January). Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 12(1):36-44.
PubMed ID: 22032844
McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich T, Belongia EA. (2014 November). Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons. Clin Infect Dis.. 59(10):1375-85.
PubMed ID: 25270645
McNeil MM, Gee J, Weintraub E, Belongia EA, Lee GM, Glanz JM,...DeStefano F. (2014 September). The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. VACCINE. 32(42):5390-8.
PubMed ID: 25108215
Sundaram ME, Meece JK, Sifakis F, Gasser R, Belongia EA. (2014 February). Medically attended respiratory syncytial virus infections in adults aged >=50 years: clinical characteristics and outcomes. CLINICAL INFECTIOUS DISEASES. 58(3):342-9.
PubMed ID: 24265361
McLean HQ, Meece JK, Belongia EA. (2014 January). Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. VACCINE. 32(4):453-7.
PubMed ID: 24291201
McClure DL, Kieke BA, Sundaram ME, Simpson M, Meece JK, Sifakis F,...Belongia EA. (2014 July). Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults =50 years old. PLoS One. 9(7):e102586.
PubMed ID: 25025344
McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K,...Belongia EA [including Meece JK.] (2015 May). Influenza Vaccine Effectiveness in the United States During 2012-13: Variable Protection by Age and Virus Type. JOURNAL OF INFECTIOUS DISEASES. 211(10):1529-40.
PubMed ID: 25406334
Belongia EA, Sundaram ME, McClure DL, Meece JK, Ferdinands J, VanWormer JJ. (2015 January). Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. VACCINE. 33(1):246-51.
PubMed ID: 24962752
Caspard H, Gaglani M, Clipper L, Belongia EA, McLean HQ, Griffin MR,...Ambrose CS. (2016 January 14). Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States. VACCINE. 34(1):77-82.
PubMed ID: 26589519
Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. (2016 August). Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 16(8):942-951.
PubMed ID: 27061888
Flannery B, Zimmerman RK, Gubareva LV, Garten RJ, Chung JR, Nowalk MP,...Fry AM [including Belongia EA, McLean HQ.] (2016 October 1). Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. J Infect Dis. 214(7):1010-9.
PubMed ID: 27190176
McLean HQ, Chow BD, VanWormer JJ, King JP, Belongia EA. (2016 October 15). Effect of Statin Use on Influenza Vaccine Effectiveness. J Infect Dis. 214(8):1150-1158.
PubMed ID: 27471318
Simpson MD, Kieke BA, Sundaram ME, McClure DL, Meece JK, Sifakis F,...Belongia EA. (2016 April). Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons. Open Forum Infect Dis.. 3(2):ofw081.
PubMed ID: 27419158
McLean HQ, Peterson SH, King JP, Meece JK, Belongia EA. (2017 May). School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015. Influenza Other Respi Viruses. 11(3):220-229.
PubMed ID: 27885805
Chung JR, Flannery B, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA,...Fry AM [including McLean HQ, Belongia EA.] Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S. J Infect Dis. 2017 July 15; 216(2):284-285.
PubMed ID: 28633308
Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G. (2017 July). Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines. 16(7):1-14.
PubMed ID: 28562111
McLean HQ, VanWormer JJ, Chow BDW, Birchmeier B, Vickers E, DeVries E,...Belongia EA. (2017 August). Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention. J Adolesc Health. 61(2):252-258.
PubMed ID: 28462786
Ferdinands JM, Fry AM, Reynolds S, Petrie J, Flannery B, Jackson ML, Belongia EA. (2017 March 1). Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. Clin Infect Dis. 64(5):544-550.
PubMed ID: 28039340
Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS,...Flannery B [including Belongia EA, McLean HQ.] (2017 August 10). Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. New Engl J Med. 377(6):534-543.
PubMed ID: 28792867
Belongia EA. (2017 December 19). Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness. J Infect Dis. 216(12):1477-1480.
PubMed ID: 29029175
Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML,...Fry AM [including Belongia EA, McLean HQ.] Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. J Infect Dis. 2018 June 20; 218(2):189-196.
PubMed ID: 29361005
King JP, McLean HQ, Meece JK, Levine MZ, Spencer SM, Flannery B, Belongia EA. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season. VACCINE. 2018 February 21; 36(9):1214-1219.
PubMed ID: 29395525
Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, Harpaz R. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. Am. J. Transplant.. 2018 March; 18(3):756-762.
PubMed ID: 29462512
Belongia EA, King JP, Kieke BA, Pluta J, Al-Hilli A, Meece JK, Shinde V. Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults =60 Years Old. Open Forum Infect Dis.. 2018 December; 5(12):ofy316.
PubMed ID: 30619907